The predictive role of flow cytometry-derived tumor potential doubling time (Tpot) in radiotherapy: Open questions and future perspectives (Review)

International Journal of Oncology

Volumn 12, Issue 2, 1998, Pages 245-256

  Antognoni, Paolo ^a,d   Terry, Nicholas H A ^d   Richetti, Antonella ^a   Luraghi, Roberto ^a   Tordiglione, Michele ^a   Danova, Marco ^b,c  

^a OSPEDALE DI CIRCOLO   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cell kinetics; Flow cytometry; Predictive assays; Radiotherapy; Tpot

Indexed keywords

CANCER RADIOTHERAPY; CELL KINETICS; CELL PROLIFERATION; FLOW CYTOMETRY; HUMAN; HYPOTHESIS; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVIEW;

BROMODEOXYURIDINE; CELL CYCLE; FLOW CYTOMETRY; FORECASTING; GUIDELINES; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; THYMIDINE; TIME FACTORS;

EID: 0031951558     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Steel GG: Cell loss from experimental tumors. Cell Tissue Kinet 1: 193-207, 1968.
2. Dolbeare F: Bromodeoxyuridine: a diagnostic tool in biology and medicine. Part I: Historical perspectives, histochemical methods and cell kinetics. Histochem J 27: 339-369, 1995.
3. Dolbeare F: Bromodeoxyuridine: a diagnostic tool in biology and medicine. Part II: Oncology, chemotherapy and carcinogenesis. Histochem J 27: 923-964, 1995.
4. Wilson GD: Assessment of human tumour proliferation using bromodeoxyuridine - Current status. Acta Oncol 30: 903-910, 1991.
5. Antognoni P, Bignardi M, Cazzaniga LF, Poli AM, Richetti A, Bossi A, Rampello G, Barbera F, Soatti C, Bardelli D, Giordano M and Danova M: Accelerated radiation therapy for locally advanced squamous cell carcinomas of the oral cavity and oropharynx selected according to tumor cell kinetics - A Phase II multicenter study. Int J Radiat Oncol Biol Phys 36: 1137-1145, 1996.
6. Wilson GD: The future of flow cytometry. Br J Radiol 24 (Suppl.): 158-162, 1992.
7. Begg A, McNally NJ, Shrieve DC and Karcher H: A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 6: 620-626, 1985.
8. Fowler JF: Rapid repopulation in radiotherapy: a debate on mechanism. The phantom of tumor treatment - Continually rapid repopulation unmasked. Radiother Oncol 22: 156-158, 1991.
9. pot) mesuré par cytométrie de flux. Bull Cancer 82: 331-338, 1995.
10. pot! Int J Radiat Oncol Biol Phys 32: 1539-1541, 1995.
11. Terry NHA, White RA and Meistrich ML: Cell kinetics: from tritiated thymidine to flow cytometry. Br J Radiol 24 (Suppl.): 153-157, 1992.
12. Riccardi A, Danova M, Wilson G, Ucci G, Dormer P, Mazzini G, Brugnatelli S, Girino M, McNally NJ and Ascari E: Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry. Cancer Res 48: 6238-6245, 1988.
13. Begg AC, Hofland I, Moonen L, Bartelink H, Schraub S, Bontemps P, Le Fur R, van den Bogaert W, Caspers R, van Glabbeke M and Horiot JC: The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report. Int J Radiat Oncol Biol Phys 19: 1449-1453, 1990.
14. Begg AC, Hofland I, van Glabbeke M, Bartelink H and Horiot JC: Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: results from the EORTC cooperative trial 22851. Semin Radiat Oncol 2: 22-25, 1992.
15. Bennett MH, Wilson GD, Dische S, Saunders MI, Martindale CA, Robinson BM, O'Halloran AE, Leslie MD and Laing JHE: Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck. Br J Cancer 65: 870-878, 1992.
16. Forster G, Cooke TG, Cooke LD, Stanton PD, Bowie G and Stell PM: Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry. Br J Cancer 65: 696-702, 1992.
17. Lochrin CA, Wilson GD, McNally NJ, Dische S and Saunders MI: Tumor cell kinetics, local tumor control, and accelerated radiotherapy: a preliminary report. Int J Radiat Oncol Biol Phys 24: 87-91, 1992.
18. pot correlation. Semin Radiat Oncol 2: 62-66, 1992.
19. Bourhis J, Wilson G, Wibault P, Bosq J, Chavaudra N, Janot F, Luboinski B, Eschwege F and Malaise EP: In vivo measurement of the potential doubling time by flow cytometry in oropharyngcal cancer treated by conventional radiotherapy. Int J Radiat Oncol Biol Phys 26: 793-799, 1993.
20. Corvò R, Giaretti W, Sanguineti G, Geido E, Orecchia R, Barra S, Margarino G, Bacigalupo A and Vitale V: Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control. Int J Radiat Oncol Biol Phys 27: 1165-1172, 1993.
21. Terry NHA and Peters LJ: Human tumor cell kinetics and treatment response: The MD Anderson experience. In: Proceedings of the 4th International Conference on Dose, Time, and Fractionation in Radiation Oncology. Prediction of Response in Radiation Therapy, Radiosensitivity and Repopulation. Paliwal B, Herbert D, Fowler JF, et al (eds). American Institute of Physics, Colchester, Vermont, pp41-52, 1993.
22. Cooke LD, Cooke TG, Forster G, Jones AS and Stell PM: Prospective evaluation of cell kinetics in head and neck squamous carcinoma: the relationship to tumour factors and survival. Br J Cancer 69: 717-720, 1994.
23. Nylander K, Anneroth G, Gustafsson H, Roos G, Stenling R and Zackrisson B: Cell kinetics of head and neck squamous cell carcinomas. Prognostic implications. Acta Oncol 33: 23-28, 1994.
24. Corvò R, Giaretti W, Sanguineti G, Geido E, Orecchia R, Guenzi M, Margarino G, Bacigalupo A, Garaventa G, Barbieri M and Vitale V: In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen. J Clin Oncol 13: 1843-1850, 1995.
25. Wilson GD, Dische S and Saunders MI: Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy. Radiother Oncol 36: 189-197, 1995.
26. Bourhis J, Dendale R, Hill C, Bosq J, Janot F, Attal P, Fortin A, Marandas P, Schwaab G, Wibault P, Malaise EP, Bobin S, Luboinski B, Eschwege F and Wilson G: Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 Gy in 7 weeks. Int J Radiat Oncol Biol Phys 35: 471-476, 1996.
27. Haustermans K, Vanuytsel L, Geboes K, Lerut T, Van Thillo J, Leysen J, Coosemans W and van der Schueren E: In vivo cell kinetic measurements in human oesophageal cancer: what can be learnt from multiple biopsies? Eur J Cancer 30A: 1787-1791, 1994.
28. Riccardi A, Danova M, Dionigi P, Gaetani P, Cebrelli T, Butti G, Mazzini G and Wilson G: Cell kinetics in leukaemia and solid tumours studied with in vivo bromodeoxyuridine and flow cytometry. Br J Cancer 59: 898-903, 1989.
29. Shimomatsuya T, Tanigawa N and Muraoka R: Proliferative activity of human tumors: assessment using bromodeoxyuridine and flow cytometry. Jpn J Cancer Res 82: 357-362, 1991.
30. Rew DA, Wilson GD, Taylor I and Weaver PC: Proliferation characteristics of human colorectal carcinomas measured in vivo. Br J Surg 78: 60-66, 1991.
31. Terry NHA, Meistrich ML, Roubein LD, Lynch PM, Dubrow RA and Rich TA: Cellular kinetics in rectal cancer. Br J Cancer 72: 435-441, 1995.
32. Rew DA, Campbell ID, Taylor I and Wilson GD: Proliferation indices of invasive breast carcinomas after in vivo 5-bromo-2′-deoxyuridine labelling: a flow cytometric study of 75 tumours. Br J Surg 79: 335-339, 1992.
33. pot in cancer of the uterine cervix: preliminary results. Int J Radiat Oncol Biol Phys 32: 1319-1329, 1995.
34. Rew DA, Thomas J, Coptcoat M and Wilson GD: Measurements of in vivo urological tumour cell kinetics using multiparameter flow cytometry. Preliminary study. Br J Urol 68: 44-48, 1991.
35. Tinnemans MMFJ, Schutte B, Lenders MHJH, Ten Velde GPM, Ramaekers FCS and Blijham GH: Cytokinetic analysis of lung cancer by in vivo bromodeoxyuridine labelling. Br J Cancer 67: 1217-1222, 1993.
36. Brons PPT, Raemaekers JMM, Bogman MJJT, van Erp PEJ, Boezeman JBM, Pennings AHM, Wessels HMC and Haanen C: Cell cycle kinetics in malignant lymphoma studied with in vivo iododeoxyuridine administration, nuclear Ki-67 staining, and flow cytometry. Blood 80: 2336-2343, 1992.
37. Erlanson M, Lindh J, Zackrisson B, Landberg G and Roost G: Cell-kinetic analysis of non-Hodgkin's lymphomas using in vivo iododeoxyuridine incorporatioin and flow cytometry. Hematol Oncol 13: 207-217, 1995.
38. Brons PPT, Haanen C, Boezeman JBM, Muus P, Holdrinet RSG, Pennings AHM, Wessels HMC and de Witte T: Proliferation patterns in acute myeloid leukemia: leukemic clonogenic growth and in vivo cell kinetics. Ann Hematol 66: 225-233, 1993.
39. Giordano M, Danova M, Mazzini G, Gobbi P and Riccardi A: Cell kinetics with in vivo bromodeoxyuridine assay, proliferating cell nuclear antigen expression, and flow cytometric analysis. Cancer 71: 2739-2745, 1993.
40. Altman DG, Lausen B, Sauerbrei W and Schumacher M: Danger of using 'optimal' cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86: 829-835, 1994.
41. Saunders MI, Dische S, Grosch EJ, Fermont DC, Ashford RF, Maher EJ and Makepeace AR: Experience with CHART. Int J Radiat Oncol Biol Phys 21: 871-878, 1991.
42. Begg AC, Moonen L, Hofland I, Dessing M and Bartelink H: Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: intratumour sampling variations. Radiother Oncol 11: 337-347, 1988.
43. pot) be compared between laboratories? A quality control study. Cytometry 19: 154-163, 1995.
44. Hoyer M, Bentzen SM, Sailing LN and Overgaard J: Influence of sampling time on assessment of potential doubling time. Cytometry 16: 144-151, 1994.
45. Ritter MA, Fowler JF, Kim Y, Lindstrom MJ and Kinsella TJ: Single biopsy, tumor kinetic analyses: a comparison of methods and an extension to shorter sampling intervals. Int J Radiat Oncol Biol Phys 23: 811-820, 1992.
46. Mazzini G, Danova M, Ferrari C, Giordano M, Dionigi P and Riccardi A: Cell proliferation and ploidy of human solid tumors: methodological experience with in vivo bromodeoxyuridine and DNA flow cytometry. Anal Cell Pathol 10: 101-113, 1996.
47. Terry NHA and Peters LJ: The predictive value of tumor-cell kinetic parameters in radiotherapy: considerations regarding data production and analysis. J Clin Oncol 13: 1833-1836, 1995.
48. Danova M, Riccardi A, Brugnatelli S, Fiocca R, Girino M, Villani L, Giordano P, Dionigi P, Giordano M, Buttini R, Ucci G and Mazzini G: In vivo bromodeoxyuridine incorporation in human gastric cancer: a study on formalin-fixed and paraffinembedded sections. Histochem J 20: 125-130, 1988.
49. Begg AC and Hofland I: Cell kinetic analysis of mixed populations using three-color fluorescence flow cytometry. Cytometry 12: 445-454, 1991.
50. Haustermans K, Hofland I, Ramaekers M, Ivanyi D, Balm AJM, Geboes K, Lerut T, van der Schueren E and Begg AC: Enrichment of tumor cells for cell kinetic analysis in human tumor biopsies using cytokeratin gating. Radiother Oncol 41: 237-248, 1996.
51. Ritter MA, Albrechtson JL, Kim YJ and Kinsella TJ: Tumor cell kinetics in mixed populations. Cytometry 16: 118-128, 1994.
52. White RA and Meistrich ML: A comment on 'A method to measure the duration of DNA synthesis and the potential doubling time from a single sample'. Cytometry 7: 486-490, 1986.
53. Carlton JC, Terry NHA and White RA: Measuring potential doubling times of murine tumors using flow cytometry. Cytometry 12: 645-650, 1991.
54. Terry NHA, White RA, Meistrich ML and Calkins DP: Evaluation of flow cytometric methods for determining population potential doubling times using cultured cells. Cytometry 12: 234-241, 1991.
55. White RA, Terry NHA and Meistrich ML: New methods for calculating kinetic properties of cells in vitro using pulse labeling with bromodeoxyuridine. Cell Tissue Kinet 23: 561-573, 1990.
56. White RA, Terry NHA, Meistrich ML and Calkins DP: Improved method for computing the potential doubling time from flow cytometric data. Cytometry 11: 314-317, 1990.
57. Antognoni P, Danova M, Tordiglione M and Terry NHA: La misurazione in vivo dei parametri di cinetica cellulare. Problematiche per il radioterapista. Radiol Med 90 (Suppl. 1): 244-246, 1995.
58. White RA and Terry NHA: A quantitative method for evaluating bivariate flow cytometric data obtained using monoclonal antibodies to bromodeoxyuridine. Cytometry 13: 490-495, 1992.
59. White RA, Pollack A and Terry NHA: Simultaneous cytokinetic measurement of aneuploid tumors and associated diploid cells following continuous labelling with chlorodeoxyuridine. Cytometry 15: 311-319, 1994.
60. Ritter MA, Fowler JF, Kim YJ, Gilchrist KW, Morrissey LW and Kinsella TJ: Tumor cell kinetics using two labels and flow cytometry. Cytometry 16: 49-58, 1994.
61. Pollack A, White RA, Cao S, Meistrich ML and Terry NHA: Calculating potential doubling time using monoclonal antibodies specific for two halogenated thymidine analogues. Int J Radiat Oncol Biol Phys 27: 1131-1139, 1993.
62. Pollack A, Terry NHA, Wu CS, Wise BM, White RA and Meistrich ML: Specific staining of iododeoxyuridine and bromodeoxyuridine in tumors double labelled in vivo: a cell kinetic analysis. Cytometry 20: 53-61, 1995.
63. pot. Int J Radiat Oncol Biol Phys 31: 847-856, 1995.
64. pot is not. Int J Radiat Oncol Biol Phys 35: 633-634, 1996.
65. Corvò R, Giaretti W, Geido E, Sanguineti G, Orecchia R, Scala M, Garaventa G, Mora E and Vitale V: Cell kinetics and tumor regression during radiotherapy in head and neck squamous-cell carcinomas. Int J Cancer 68: 151-155, 1996.
66. Bataini JP, Jaulerry C, Brunin F, Ponvert D and Ghossein NA: Significance and therapeutic implications of tumor regression following radiotherapy in patients treated for squamous cell carcinoma of the oropharynx and pharyngolarynx. Head Neck 12: 41-49, 1990.
67. Jaulerry C, Dubray B, Brunin F, Rodriguez J, Point D, Blaszka B, Asselain B, Mosseri V, Brugere J and Cosset JM: Prognostic value of tumor regression during radiotherapy for head and neck cancer: a prospective study. Int J Radiat Oncol Biol Phys 33: 271-279, 1995.